Artal Group’s Denali Therapeutics DNLI Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-502,899	Closed	-$11.7M	–	27
2024 Q2	$11.7M	Hold	502,899	–	–	0.3%	36
2024 Q1	$10.3M	Sell	502,899 -300,000	-37%	-$6.16M	0.26%	43
2023 Q4	$17.2M	Hold	802,899	–	–	0.57%	23
2023 Q3	$16.6M	Hold	802,899	–	–	0.71%	22
2023 Q2	$23.7M	Hold	802,899	–	–	0.73%	18
2023 Q1	$18.5M	Buy	802,899 +2,899	+0.4%	+$66.8K	1.1%	23
2022 Q4	$22.2M	Buy	800,000 +200,000	+33%	+$5.56M	1.24%	24
2022 Q3	$18.4M	Hold	600,000	–	–	0.79%	28
2022 Q2	$17.7M	Hold	600,000	–	–	0.94%	27
2022 Q1	$19.3M	Hold	600,000	–	–	0.81%	30
2021 Q4	$26.8M	Buy	600,000 +100,000	+20%	+$4.46M	0.73%	31
2021 Q3	$25.2M	Hold	500,000	–	–	0.56%	39
2021 Q2	$39.2M	Hold	500,000	–	–	0.8%	22
2021 Q1	$28.6M	Buy	500,000 +100,000	+25%	+$5.71M	0.5%	38
2020 Q4	$33.5M	Hold	400,000	–	–	0.72%	35
2020 Q3	$14.3M	Sell	400,000 -50,000	-11%	-$1.79M	0.35%	53
2020 Q2	$10.9M	Sell	450,000 -50,000	-10%	-$1.21M	0.3%	55
2020 Q1	$8.76M	Buy	500,000 +100,000	+25%	+$1.75M	0.37%	44
2019 Q4	$6.97M	Hold	400,000	–	–	0.27%	54
2019 Q3	$6.13M	Hold	400,000	–	–	0.25%	57
2019 Q2	$8.3M	Hold	400,000	–	–	0.34%	49
2019 Q1	$9.29M	Sell	400,000 -100,000	-20%	-$2.32M	0.38%	43
2018 Q4	$10.3M	Hold	500,000	–	–	0.38%	29
2018 Q3	$10.9M	Hold	500,000	–	–	0.28%	30
2018 Q2	$7.63M	Buy	500,000 +50,000	+11%	+$763K	0.16%	37
2018 Q1	$8.86M	Sell	450,000 -50,000	-10%	-$985K	0.11%	30
2017 Q4	$7.82M	Buy	+500,000	New	+$7.82M	0.12%	25